BACKGROUND: Sperm from several species, including the human, make direct contact with the endosalpinx. Although this is known to be bene®cial to sperm function, the speci®c mechanisms mediating the adhesion are poorly understood. METHODS: Short linear oligopeptides containing the amino acid sequence Arg-Gly-Asp (RGD) or a scrambled sequence (GRGES) were incorporated into an established sperm±endosalpingeal binding assay. In addition, the ability of¯uorescent latex beads coated with an RGD oligopeptide to bind speci®cally to sperm and/or epithelium was also determined. RESULTS: Signi®cantly fewer sperm associated per ®eld of isthmic epithelium in the presence of 62.5 mmol/l GRGDTP (1.18 T T 0.41; mean T T SEM, P < 0.05) and 250 mmol/l RGDV (1.17 T T 0.29; P < 0.01) compared with the control incubation (3.34 T T 0.45). There was no difference in sperm binding to ampullary epithelium in the presence of any of the oligopeptides tested. Moreover, no beads were observed bound to sperm whereas signi®cantly more RGD-coupled beads bound to isthmic epithelium compared with ampullary epithelium (1.47 T T 0.26 versus 0.72 T T 0.16 P < 0.01) and this increased in a dose-dependent manner. CONCLUSIONS: These ®ndings indicate that the recognition between the RGD sequence and integrin receptors may contribute to the interaction between sperm and the human endosalpinx in the isthmic but not in the ampullary region of the uterine tube.
Introduction
It is now generally accepted that during the residence of mammalian sperm within the female reproductive tract, sperm transiently adhere to the epithelial cells that line the internal lumen of the uterine (Fallopian) tubeÐthe endosalpinx (reviewed by Scott, 2000) . Numerous studies, in various nonhuman mammalian species, have shown that this interaction has bene®cial in¯uence on sperm function. For example, sperm in co-culture with endosalpingeal cells have been shown to retain their viability, motility and fertilizing capacity longer than sperm incubated alone or with other cell types (Smith and Yanagimachi, 1990; Pollard et al., 1991; Smith and Nothnick, 1997) . In addition, the binding of sperm to the isthmic region of the uterine tube is thought to contribute to the formation of a sperm reservoir Lefebvre et al., 1995; Suarez, 1998) . This serves to maintain sperm fertilizing ability and delay sperm movement into the ampulla until ovulation has occurred, thereby ensuring that a functional population of sperm is available to meet the oocyte.
By contrast, our knowledge of sperm±endosalpingeal interactions in the human female reproductive tract remains limited.
However, there is accumulating evidence to suggest that the uterine tube is not merely a`passive conduit for gametes' (Hunter, 1998) , but provides a dynamic environment that may play a role in regulating and maintaining sperm function. It has been shown that human sperm bind to the endosalpinx (Pacey et al., 1995a) , and that more sperm bind to cells from the isthmic region of the uterine tube compared with the ampulla (Baillie et al., 1997) . In addition, a number of investigators have described the positive effects on human sperm function after co-incubation with endosalpingeal cells, including prolonged viability (Morales et al., 1996; Ellington et al., 1998) , increased motility (Guerin et al., 1991; Yeung et al., 1994; Yao et al., 2000) , and a regulatory effect on sperm capacitation (Murray and Smith, 1997; Petrunkina et al., 2001) .
Despite the increased awareness of the importance of sperm±endosalpingeal interaction to reproductive success, the speci®c molecular mechanisms mediating this interaction in the human are poorly understood. In non-human species, sperm±epithelial interaction has been shown to involve carbohydrate recognition (reviewed by Suarez, 2001 ), but in the human a number of workers have suggested that integrins, a family of cell adhesion molecules, may also be involved. This is because integrins are known to have a widespread role in many cell±cell and cell±matrix interactions (Ruoslahti and Pierschbacher, 1986; including fertilization and implantation (reviewed by Klentzeris, 1997) . Experimental evidence to support this hypothesis is, however, currently lacking but it has been demonstrated that the b1 integrins, a4, a5, a6 and av chains (Glander and Schaller, 1993; Trubner et al., 1997) are expressed on the plasma membrane of human sperm. Also expressed are the proteins ®bronectin and vitronectin which contain the amino acid sequence Arg-Gly-Asp (RGD) that is the recognition sequence for a number of integrins. Unfortunately, very little is known about the expression of integrins or RGD-containing matrix proteins on the apical surface of endosalpingeal cells, although b3 and av integrin subunits are known to be expressed and may play a role in extrauterine implantation (Sulz et al., 1998) .
In their studies to investigate the role of the RGD adhesion sequence in sperm binding to the oolemma, Bronson and Fusi (1990a; b) used a novel technique in which oligopeptides containing the RGD sequence (or a scrambled peptide) were introduced into an established assay of sperm±oolemma interaction. Using this technique, they were able to demonstrate that the numbers of sperm binding to the oolemma were reduced in the presence of oligopeptides containing the RGD sequence but remained similar to control values when scrambled oligopeptides were present. In addition, it was shown that the RGD sequence is speci®cally recognized by integrins present on the oolemmal surface (Fusi et al., 1993) . Since this experimental system is very similar to an in-vitro assay we have used previously to quantify the numbers of sperm bound to explants of human endosalpinx (Baillie et al., 1997) , we have chosen to use this approach to study the role of integrins and the RGD sequence in mediating human sperm± endosalpingeal interactions.
Materials and methods
For these experiments the oligopeptides RGDV, GRGDTP (both containing the RGD sequence) and the scrambled peptide GRGES were obtained from BACHEM Ltd (UK). All were shown by the manufacturer to be >99% pure (by thin layer chromatography). Upon arrival at the laboratory, each lyophilized oligopeptide was reconstituted with 1 ml of Earle's balanced salt solution (EBSS) to give a ®nal stock concentration of 11.24 mmol/l (RGDV), 8.35 mmol/l (GRGDTP) and 1.98 mmol/l (GRGES). Each peptide was then divided into aliquots and stored at ±20°C until use.
Patient recruitment and surgery
The speci®c details regarding the recruitment of patients, surgical procedures and the isolation of endosalpingeal explants for use in experiments have been fully described elsewhere (Pacey et al., 1995a) . Brie¯y, tubal tissue was obtained from 19 pre-menopausal women undergoing routine abdominal hysterectomy for benign gynaecological conditions not affecting the uterine tubes, at the Royal Hallamshire Hospital, Shef®eld, UK. The study was approved by the South Shef®eld Research Ethics Committee, and all patients' gave their written consent. Uterine tubes from patients at any stage of the menstrual cycle were obtained, since it has been shown previously that the level of sperm binding to the human endosalpinx is independent of reproductive hormones (Baillie et al., 1997) .
Material from the ampulla was taken from a region in the distal portion of the uterine tube, 1±2 cm from the cut ®mbrial end and isthmic tissue from the region closest to the utero-tubal junction in the proximal portion of the tube. Epithelial mucosa was isolated from the underlying musculature by grasping the folds of mucosa with watchmakers' forceps (Fisher Scienti®c, UK) and cutting them away with ®ne-pointed scissors (Fisher Scienti®c). Sections of mucosa were then carefully cut to produce explants of~1 mm 3 . The explants were placed into separate wells (three explants per well, four wells per tubal region) of an untreated,¯at-bottomed tissue culture plate (Gibco BRL, UK) containing 500 ml of tissue culture medium composed of a 50/50 mixture of Ham's F-12/Dulbecco's modi®ed Eagle's medium (DMEM) containing 1% L-glutamine (200 mmol/l), 5% of a 50/50 mixture of Nu-serum/fetal bovine serum, 1% penicillin±streptomycin solution (containing 5000 IU/ml penicillin and 5000 mg/ml streptomycin), 2% HEPES buffer (1 mol/l) and 3% sodium bicarbonate (7.5%) solution. Explants were then incubated overnight in a humid atmosphere of 5% CO 2 in air at 37°C, before being used in experiments on the following day. Only explants obtained from a single patient were used in each experiment.
Preparation of sperm
Motile sperm were obtained from the semen of sperm donors attending the Andrology Laboratory in the Jessop Wing of the Royal Hallamshire Hospital. All donors adhered to a 2 day period of sexual abstinence prior to sample production and were all of proven fertility producing ejaculates containing b60Q10 6 sperm/ml and 15% ideal morphological forms (World Health Organization, 1999) . Sperm were isolated from seminal plasma using a direct swim-up technique (Mortimer, 1990) . Brie¯y, aliquots of 300 ml of semen were overlaid with 600 ml of EBSS containing 0.3% (w/v) human serum albumin (HSA) (Sigma Chemicals, UK) and incubated in a humid atmosphere of 5% CO 2 in air at 37°C for 1 h. After 1 h the top 50% of medium was removed from each tube, the samples pooled and the concentration manually checked using a Neubauer haemocytometer. The sperm sample was adjusted to 5Q10 6 /ml with EBSS containing 0.3% (w/v) HSA, and the concentration manually checked as before using a Neubauer haemocytometer.
Experiment 1: The effect of RGD and non-RGD oligopeptides on sperm function To assess the effect of the oligopeptides on sperm function prior to their use in sperm±endosalpingeal interaction assays, a number of preliminary experiments were performed. This was to preclude the possibility that any effect in the sperm±endosalpingeal interaction assay was a direct result of the peptide sequence blocking a receptorintegrin interaction and not as a result of a deleterious effect of the oligopeptides on sperm function. In addition, a sperm±hamster oocyte interaction assay was performed as a positive control to establish that the RGD oligopeptides were working as previously described (Bronson and Fusi, 1990a; b) .
Measurement of sperm function
Sperm were isolated from the ejaculates of six donors and prepared as described above. To three aliquots, sperm were incubated with 250 mmol/l of each of the three oligopeptides, and a fourth incubated with medium alone served as a control. Both at the start of the incubation and after 3 h incubation in a humid atmosphere at 37°C, two 10 ml aliquots of the sperm suspension were removed from each incubation to determine the percentage motility and also the viability and acrosomal status of the sperm population. To determine the percentage of motile sperm in each of the incubations, each 10 ml aliquot was loaded into a 20 mm depth Microcell chamber (Conception Technologies, USA) and analysed using a Hamilton Thorn Motility Analyser (Hamilton Thorn Research, USA). The machine used was running version 10.8 of the analysis software and was operated with the following settings: number of frames acquired, 60; minimum contrast, 80; minimum cell size, 2; and magni®cation factor, 4.78. At least 200 sperm were examined from each incubation condition from up to 16 ®elds of view.
To determine the viability and acrosomal status of sperm in the incubation, the second 10 ml aliquot was added to 100 ml of hypoosmotic swelling (HOS) solution (World Health Organization, 1999) and incubated for 30 min at 37°C. The suspension was then spotted onto a poly-L-lysine-coated slide and allowed to air-dry before being ®xed in absolute methanol for 2 min. The ®xed slides were then stained to evaluate the acrosomal status using the technique described by Moore et al. (1987) using a monoclonal antibody donated to this study by Professor Moore. Brie¯y, 20 ml of neat primary monoclonal antibody (mAb 18.6) was added to the slides and incubated for 1 h in a humid atmosphere at 37°C. The slides were then washed in 0.1 mol/l phosphate-buffered saline (PBS), and 20 ml of the secondary antibody (anti-mouse IgG FITC conjugate) was added at a 1:40 dilution. Slides were placed in a humid chamber as before and incubated for 30 min at 37°C before being washed twice in PBS and mounted with MOWIOL (Calbiochem, UK) and kept in the dark until analysis. Analysis was always performed within 2 days of the experiment and b200 sperm were counted per experimental condition. The numbers of live acrosome-intact, dead acrosome-intact, live acrosome-reacted and dead acrosome-reacted sperm were recorded. Live sperm with an intact cell membrane and an intact acrosome display coiled tails and uorescence over the acrosome region, whereas non-viable or acrosome-reacted cells were those displaying straight tails and a lack of¯uorescence or patchy¯uorescence over the head region.
Inhibition of human sperm±hamster oocyte binding
Sperm±hamster oocyte binding assays were performed following the method developed by Yanagimachi et al. (1976) , but with slight modi®cations as described below. Brie¯y, female golden hamsters (25±30 days old) were induced to ovulate by an i.p. injection of 30 IU of pregnant mare serum gonadotrophin (PMSG; Folligon, UK) on the morning of post-estrous vaginal discharge. Approximately 72 h later, each animal received an i.p. injection with hCG (Chorulon; Intervet, UK). The animals were killed 20±24 h later by an overdose of pentarbarbitone sodium (Euthatal; J.M.Loveridge plc, UK) and the oviducts removed. The oocytes were freed from the surrounding cumulus cells by a 15 min incubation with 0.1% (w/v) bovine testicular hyaluronidase type IV-S (1100 IU/mg; Sigma Chemicals) diluted in Biggers±Whitten±Whitingham medium (BWW) supplemented with 1% (w/v) bovine serum albumin (BSA). The oocytes were made zona pellucida (ZP)-free by incubation in 0.1% (w/v) bovine pancreatic trypsin type III for 1 min (Sigma Chemicals). The zona-free oocytes were rinsed thoroughly in BWW medium and incubated at 37°C in fresh BWW medium containing 1% (w/v) BSA.
Prior to each experiment, the zona-free oocytes were randomly allocated into four groups and then transferred into 100 ml droplets contained in a 35 mm diameter Corning plastic Petri dish (VWR Int. Ltd, UK), with~10 oocytes per drop. The drops were then overlain with 2 ml of mineral oil (BDH, UK). Into a separate Petri dish, 4Q150 ml drops of a sperm suspension from a single donor (prepared as described above and containing 5Q10 6 sperm per ml) were prepared and overlain with mineral oil. To three of the drops of sperm or zonafree oocytes, an aliquot of each oligopeptide was then added to give a ®nal concentration of 250 mmol/l. To the fourth, the same volume of medium was added as a control. The drops of sperm and oocytes were then preincubated for 30 min at 37°C before removing 100 ml of sperm suspension and adding it to the corresponding incubation of oocytes, giving a total volume of 200 ml per droplet. This dish was incubated overnight for 15±17 h at 37°C in a humid atmosphere of 5% CO 2 in air.
The following morning, the oocytes were gently washed with fresh BWW to remove unbound sperm and were then mounted on a slide containing four wax spots, compressed with a coverslip and examined with a Nikon Diophot using a Q40 objective. The number of bound sperm per oocyte was examined for each experimental group and control.
Experiment 2: The effect of RGD and non-RGD oligopeptides on sperm±epithelial binding For each experiment, sperm and epithelial explants were preincubated with the oligopeptides separately for 30 min at 37°C, with a control group being incubated with medium alone under the same conditions. Three working concentrations of each oligopeptide were used in this experiment (250, 62.5 and 15.5 mmol/l) and these were prepared by serial dilution from a thawed aliquot of frozen stock solution on each day as required. After the 30 min preincubation period, the medium overlying the explants was removed and 500 ml of the corresponding sperm suspension (preincubated with the same concentration of oligopeptide) was added. As such, explants were exposed to 2.5Q10 6 sperm. These were then incubated for 1 h and processed according to the methods of Baillie et al. (1997) . Brie¯y, following the incubation, the suspension was removed from the wells and 500 ml of fresh (sperm free) warm EBSS was added and the well gently agitated for 1 min (to remove unbound sperm) and the procedure repeated once more before the addition of 500 ml of 3% (v/v) of 25% glutaraldehyde (Sigma Chemicals) in 0.1 mol/l PBS and left overnight at 4°C. The following day the tissue was rinsed several times with PBS, stained for 30 s with Gill's haematoxylin and cleared with several changes of 50:50 PBS:glycerol over 4 h. Explants were then mounted in PBS:glycerol under a coverslip, sealed with silicone grease. These were then observed using a Q100 oil immersion objective and the number of sperm bound to the epithelial surface in each ®eld of view (equivalent to a surface area of 0.03 mm 2 ) were recorded. A total of 25 microscope ®elds per experimental condition was examined in this way and the data used to determine a mean number of bound sperm per microscope ®eld (0.03 mm 2 ) per peptide concentration. The ®elds to be analysed were selected using a systematic random sampling method (Mayhew, 1991) and the number of replicates (®elds examined) to provide a result with a sampling error of less than T5% determined by performing a`progressive mean analysis' (Williams, 1977) . Only those ®elds that contained a¯at area of epithelium as identi®ed by the presence of ciliated cells were included for analysis.
Experiment 3: Determining the location of the RGD adhesion sequence To determine the location of the RGD adhesion sequence, the oligopeptides RGDV and GRGES were coupled to 6 mm diameter FluoresbriteÔ YellowGreen (YG) carboxylate Polysciences Inc. (Warrington, USA) latex beads that were then employed in a variation of the binding assay used in experiment 2 and in a series of coincubations with sperm. The beads were obtained as a 2.5% suspension, at a stock concentration of 1.05Q10 8 and the oligopeptides were co-valently coupled to them following the manufacturer's protocol and binding kit. As a control, an aliquot of beads was processed in the same manner but in the absence of any peptide. For each experiment, the beads were re-suspended in 500 ml of EBSS containing 0.3% HSA to concentrations of 2Q10 6 , 5Q10 6 and 10Q10 6 beads per ml.
For experiments with endosalpingeal explants, 500 ml of the bead suspension (oligopeptide-coupled or control) were added to each well of explants and placed in the incubator at 37°C for 1 h. During the 1 h incubation, the plate was randomly shaken to assist the beads in making contact with an area of epithelium. This step was deemed necessary since, unlike sperm, the beads are not motile. Following the incubation, the bead suspension was removed and the explants were washed twice in EBSS to remove unbound beads and subsequently processed as for the sperm binding assay described in experiment 2.
For incubations with sperm, highly motile suspensions of donor sperm were prepared and adjusted to 20Q10 6 per ml. A 10 ml aliquot of each sperm suspension and a 10 ml aliquot of the bead suspension (containing 1.05Q10 8 beads per ml) were placed onto a glass slide and mixed thoroughly using a pipette tip. A coverslip was applied and the slides were placed into a humid atmosphere at room temperature for 10 min prior to observing the preparation at Q100 magni®cation using an Olympus BH2 microscope (Olympus, Japan). The number of beads that were bound to the surface of motile sperm was then determined when performing an immunobead test for sperm antibodies during semen analysis (Mortimer, 1994) .
Experiment 4: Competitive inhibition experiments
To determine the speci®city of the binding between the RGD sequence in the oligopeptides coupled to¯uorescent beads and the RGDbinding receptors on sperm and/or epithelium (determined in experiment 3), the binding of RGDV-coupled beads in the presence of soluble RGDV or GRGES was assessed. Soluble RGDV and GRGES were added to the assay at the concentration of 250 mmol/l and RGDV-coupled beads were added to each incubation at a concentration of 5Q10 6 .
Statistical analysis
Regression analysis and analysis of variance were performed to compare the differences between the numbers of sperm or beads bound to each tubal region in the control groups and the various treatment groups. Student's t-test was used to examine the differences between human sperm±hamster oocyte adhesion in the control and in the presence of oligopeptide. All statistical tests were performed using the Statistical Package for Social Scientists (USA).
Results

Experiment 1
Following a 3 h incubation of sperm with 250 mmol/l of RGDV, GRGDTP or GRGES, the percentage of motile, viable and live acrosome-intact sperm remained unchanged from that observed in the control incubations. Typically, the percentage of motile and viable sperm were >68 and >94% respectively with >94% of sperm with intact acrosomes. Conversely, when oligopeptides were co-incubated with sperm and zona-free hamster oocytes, signi®cantly (P < 0.05) fewer sperm were adherent to the oocytes in the presence of RGDV (3.90 T 2.43) when compared with the control incubation (18.07 T 4.46). Although numerically fewer sperm were adherent in the presence of GRGDTP (9.04 T 2.57) and GRGES (14.68 T 6.17), these were not signi®cantly different from other treatments including the control. Data shown are the mean T SEM for six semen samples incubated with pooled zona-free hamster oocytes from 18 hamsters. Figure 1 shows the mean number (T SEM) of sperm bound per 0.03 mm 2 of epithelium obtained from the tubal isthmus and ampulla in the presence of three concentrations of each oligopeptide. As would be expected from our previous work (Baillie et al., 1997) , in the absence of any of the oligopeptides signi®cantly (P < 0.05) more sperm bound to isthmic tissue (3.34 T 0.45) compared with tissue from the ampulla (1.81 T 0.39). Moreover, in the presence of oligopeptides, the numbers of sperm bound to ampullary tissue was not signi®cantly different at any of the concentrations or oligopeptides tested. However, with regard to tissue from the isthmus there were signi®cantly fewer sperm bound in the presence of 62.5 mmol/l GRGDTP (1.18 T 0.41, P < 0.05) as well as 250 mmol/l RGDV (1.17 T 0.29, P < 0.01) when compared with the control (3.34 T 0.45). Interestingly, in the presence of GRGES (which does not contain an RGD sequence), although the numbers of sperm bound at the three doses tested were numerically lower than that in the control incubation (no oligopeptide), they were not signi®cantly different from it.
Experiment 2
Experiment 3
In this experiment,¯uorescent beads to which RGDV and GRGES had been coupled were incubated with motile sperm and also with explants of epithelium from the isthmic and ampullary portions of the uterine tube. As a control, beads with no coupled protein were incubated in parallel and under the same conditions. During co-incubations with sperm from six ejaculates, <1% of sperm in each treatment were seen to have beads bound to them. This was despite sperm making numerous visible contacts with the beads. Incubations were observed at a variety of time-points between 5 and 60 min with the same behaviour being observed on each occasion. As such, it was concluded that the beads were unable to bind to sperm.
During co-incubation with epithelial cells the situation was rather different. Following co-incubations with explants from the tubal ampulla, less than one¯uorescent bead was observed binding per 0.03 mm 2 of epithelium and this was not signi®cantly different between protein-coupled or control beads. Moreover, the number of beads binding to ampullary epithelium did not vary as a function of the bead concentration (Figure 2) . However, when co-incubated with explants from the tubal isthmus, analysis of variance indicated that there was both a signi®cant effect of bead type (P = 0.006) and concentration (P = 0.003) on the number bound to the epithelial surface (Figure 2 ). For example, at a bead concentration of 5Q10 6 per ml, signi®cantly more RGDV-coupled beads were bound per ®eld of epithelium (1.47 T 0.26) than GRGES-coupled (0.67 T 0.24; P < 0.05) or uncoupled (0.30 T 0.07; P < 0.01). Moreover, at a bead concentration of 10Q10 6 per ml, there were signi®cantly (P < 0.05) more RGDVcoupled beads bound per ®eld of epithelium (2.38 T 0.48) than uncoupled (0.77 T 0.17). In addition, at a concentration of 10Q10 6 RGDV-coupled beads, there were signi®cantly more beads (P < 0.01) bound per ®eld than at an RGDV-coupled bead concentration of 2Q10 6 per ml (0.43 T 0.06). This effect was not observed with GRGES-coupled or uncoupled (control) beads, although with increasing bead concentration there were numerically more beads bound to the epithelial surface.
Comparing the number of RGDV-coupled beads binding to the ampullary or isthmic epithelium (Figure 2) , it was clear that greater numbers of beads bound to tissue from the tubal isthmus. This was signi®cantly different at concentrations of 5Q10 6 (P < 0.001) and 10Q10 6 beads per ml (P < 0.01). However, there was no signi®cant difference between the numbers of GRGES-coupled or control (uncoupled) beads bound per tubal region. With regard to the spatial distribution of beads binding to explants from either region, this was unremarkable with no obvious pattern or distribution being observed. Figure 3 shows the results of the experiments in which 5Q10 6 RGDV-coupled beads per ml were incubated with explants from the tubal isthmus and ampulla in the presence or absence of 250 mmol/l of soluble RGDV and GRGES. With ampullary tissue, the presence of soluble RGDV or GRGES made no difference to the number of beads bound. However, the binding of RGDV-coupled beads to isthmic tissue was competitively inhibited in the presence of soluble RGDV (P < 0.05) but not GRGES.
Experiment 4
Discussion
Sperm interaction with the female reproductive tract is of crucial importance during mammalian reproduction (Scott, 2000) . The importance of intimate membrane-to-membrane contacts between human sperm and the apical surface of endosalpingeal cells has been demonstrated in a number of experimental systems. For example, Murray and Smith (1997) used a novel method to isolate membrane vesicles of the apical surface of the human endosalpinx that could then be incubated with human sperm and were shown to enhance sperm motility and delay capacitation. Alternatively, Kervancioglu et al. (2000) were able to demonstrate that sperm contact with endosalpingeal cells had a positive effect on sperm motility parameters that was lost when sperm were prevented from making direct contact by being separated from the cells by a microporous membrane. Both of these studies illustrate the potential bene®t of direct sperm±epithelial interaction, but to date the molecular basis of this interaction has not been fully elucidated in any species, including the human.
In many non-human mammals, it has been proposed that an important mechanism mediating sperm±epithelial binding is the interaction between surface-associated sperm lectins and oligosaccharides present on the epithelial surface. This has been demonstrated by the ability of species-speci®c sugars to inhibit sperm±epithelial binding in both in-vivo (Demott et al., 1995) and in-vitro systems (Dobrinski et al., 1996; Green et al., 2001) . Ignotz et al. (2001) have recently proposed the identity of a carbohydrate-binding protein on bull sperm that may be involved in this process. However, it has been suggested that this carbohydrate-mediated interaction may only serve to ®rst catch' the sperm and to bring the sperm into close contact with the epithelial surface, and to prepare the underlying mechanisms that may still be involved in the communication between sperm and the endosalpinx (Wagner et al., 2002) .
This study has, therefore, examined the role in human sperm±endosalpingeal interactions of the widespread cell adhesion mechanism involving the recognition between the Arg-Gly-Asp (RGD) adhesion sequence and certain integrins (Ruoslahti and Pierschbacher, 1986) . To do this, a methodological approach previously used to study sperm±oolemma binding (Bronson and Fusi, 1990a; b) was modi®ed for use in a simple in-vitro assay that can quantify the ability of the human endosalpinx to bind sperm (Baillie et al., 1997) . From the experiments described in this report, it is proposed that the binding of human sperm to the human endosalpinx in the isthmic region of the uterine tube could be mediated in part by a mechanism that involves the Arg-Gly-Asp (RGD) adhesion sequence. The evidence for this comes from the experiments shown in Figure 1 , where the addition of RGD-containing oligopeptides, at some concentrations, can reduce the numbers of sperm bound to isthmic but not ampullary explants. However, a simple competitive inhibition was not observed for any of the peptides tested, suggesting that the mechanism could be more complicated than that observed for sperm± oolemma binding. This is supported by the fact that in our experiments, it was not possible to reduce to zero the numbers of sperm bound to the epithelium in either isthmic or ampullary tissue. Moreover, the range of concentrations chosen was the same as that used by Bronson and Fusi (1990a; b) and it may be possible that these are inappropriate to achieve the same level of inhibition seen by these authors. However, the limited supply of human tissue prevented a wider range of concentrations to be tested.
The fact that¯uorescent beads, to which RGD oligopeptides have been coupled, preferentially bound to the isthmic but not ampullary epithelium, in a dose-dependent manner (Figure 2 ) suggest that the integrin is located on the epithelial surface. This could be inhibited in the isthmus (but not in the ampulla) by the addition of soluble RGD into the assay (Figure 3) . However, the presence of the non-RGD-containing peptide GRGES could also inhibit binding to some extent (but not signi®cantly). This was a somewhat surprising result but not entirely unexpected since Bronson and Fusi (1990b) described that high concentrations of the peptide GRGES could sterically interfere with RGD recognition sites, even if the recognition sequence was not occupied. Surprisingly, very little is known about the integrin expression on the human endosalpinx. It has been shown by Sulz et al. (1998) that the integrin subunits b3 and av are expressed, but any regional differences that may account for our ®ndings in Figure 2 have yet to be observed. It is known that only ®ve integrin molecules speci®cally recognize the RGD sequence (Ruoslahti and Pierschbachher, 1997) and so these should be relatively easy to detect in the human endosalpinx using either immunohistochemistry and/or molecular techniques and to identify expression changes between the isthmus and the ampulla. Moreover, since the binding of integrins to their ligands (in this case presumably a sperm protein containing RGD) can trigger intracellular signalling pathways within the cell (Schwartz and Ginsberg, 2002) , it is interesting to speculate what events may be induced in the endosalpinx following sperm binding by this mechanism. For example, it has been shown previously in the horse (Ellington et al., 1993a) that the intracellular calcium level is elevated following sperm binding to epithelial cells. Furthermore, in a separate study by the same authors (Ellington et al., 1993b) , it was shown that the proteins secreted by uterine tube epithelial cells of the bovine were altered following co-incubation with sperm. This implies the existence of a subtle mechanism of crosstalk between sperm and epithelial cells and this is an important concept in our understanding of these events in human reproduction. It is interesting that the development of unfertilized Xenopus eggs can be triggered by the addition of oligopeptides containing RGD (Iwao and Fujimura, 1996) and therefore that intracellular signalling of the endosalpingeal cells can occur through this route should not be surprising.
In contrast to the identity of the integrin receptor on the endosalpinx, it is interesting to speculate on the nature of the corresponding ligand that is presumably present on sperm. There is a number of proteins known to be present on the outer lea¯et of the sperm plasma membrane and which contain an RGD sequence and are therefore likely candidates for the sperm ligand in sperm±epithelial binding. These include p47 (Jansen et al., 2001 ) and ®bronectin and vitronectin . Whilst little is known about the expression of p47 on human sperm, it is known that both ®bronectin and vitronectin are only expressed in capacitated (or acrosome-reacted) cells . This is consistent with a role for them in binding to the oolemma, but is confusing in the context of sperm storage in the tubal isthmus. This is because it is generally considered that the mechanism by which sperm are ultimately released from binding sites on the epithelium is due to changes in the sperm plasma membrane associated with sperm capacitation, rather than by changes in the epithelial surface. There are two lines of evidence for this. The ®rst is the fact that the number of binding L.Reeve, W.L.Ledger and A.A.Pacey sites on the epithelial surface appears to be independent of the changes in reproductive hormones, both in the human (Baillie et al., 1997) and in other non-human mammals Lefebvre et al., 1995) . The second is from experiments in non-human species that have shown that uncapacitated sperm are preferentially able to bind to the endosalpinx (Kervancioglu et al., 1994; Lefebvre et al., 1996; Fazeli et al., 1999) and that the ability of sperm to bind sugars is reduced in capacitated sperm (Demott et al., 1995; Revah et al., 2000) . As such, the fact that the only known RGD-containing proteins on the sperm plasma membrane are exposed following capacitation would seem inconsistent with the idea that uncapacitated human sperm are able to bind to the isthmic epithelium by this mechanism. However, it remains possible that there are other proteins on uncapacitated sperm that have yet to be identi®ed and that contain an RGD sequence. Moreover, it is possible that capacitated human sperm still have the capacity to bind to the human endosalpinx. Since human sperm capacitation is dif®cult to study and it has not yet been possible to determine the capacitational status of bound sperm, it unclear whether capacitated human sperm are different from uncapacitated sperm in their epithelial binding characteristics. In addition, previous reports from our group (Pacey et al., 1995b) have shown how hyperactivated motility is associated with the ability of human sperm to detach from their connection with the endosalpinx, yet hyperactivated sperm often go on to reattach to other cells. Since hyperactivation is considered a visible marker of capacitation (Mortimer et al., 1997) , then this would imply that capacitated human sperm can bind to the endosalpinx at least in vitro. This therefore leads to the question as to the mechanism by which human sperm are released from their epithelial connections in order to take part in fertilization. Perhaps the answer lies in subtle changes in the endosalpinx rather than changes in sperm that have been previously suggested. In our experiments we have shown that fewer RGD-coupled beads bind to ampullary epithelium, implying that there are fewer sperm-binding integrins present in the ampulla. Perhaps, then, as human sperm slowly pass through the uterine tube it is the combined effect of the wider lumen and reduced sperm-binding ability of the epithelium that allows sperm to be available in the tubal lumen for fertilization.
Finally, although the data in this report would suggest an important role for the RGD sequence in human sperm± epithelial interaction, it remains highly likely that other processes may also be involved. It is evident from our study that the addition of RGD oligopeptides cannot reduce to zero sperm±epithelial interaction in either isthmic or ampullary tissue and this in turn implies that other mechanisms may be involved in the process.
In conclusion, this work provides the ®rst evidence for a molecular basis of how human sperm bind to the isthmic region of the uterine tube and how physiological changes in sperm and epithelial cells may be mediated. This is an important step forward in our understanding of the early events surrounding human conception, and, whilst there is much work to be done, it would be interesting to speculate whether dysfunction in the integrin expression in the endosalpinx of some women may be an as yet unde®ned contributor to their infertility.
